Patents Assigned to Shire Holdings AG
  • Quinazoline derivatives and their use in the treatment of thrombocythemia
    Patent number: 7700608
    Abstract: A method for the treatment of thrombocythemia in a subject comprising administering a therapeutically effective amount of compounds having the formulas (I) through (III) or equilibrating forms thereof.
    Type: Grant
    Filed: August 3, 2005
    Date of Patent: April 20, 2010
    Assignee: Shire Holdings AG
    Inventor: Richard Franklin
  • QUINAZOLINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF THROMBOCYTHEMIA
    Publication number: 20100093772
    Abstract: A method for the treatment of thrombocythemia in a subject comprising administering a therapeutically effective amount of compounds having the formulas (I) through (III) or equilibrating forms thereof.
    Type: Application
    Filed: October 16, 2009
    Publication date: April 15, 2010
    Applicant: Shire Holdings AG
    Inventor: Richard Franklin
  • Treatment of bone diseases
    Patent number: 7078059
    Abstract: The invention provides a method for enhancing bone formation, inhibiting osteoclastic differentiation and/or activating osteoblastic differentiation whereby to manage, treat or achieve prophylaxis of bone disease which comprises administering to a human or animal subject suffering from, or susceptible to bone disease a therapeutically or prophylactically effective amount of a lanthanum compound.
    Type: Grant
    Filed: June 26, 2001
    Date of Patent: July 18, 2006
    Assignee: Shire Holdings AG
    Inventors: Nigel D. Atherton, Joseph William Totten, Michael David Gaitonde
  • Quinazoline derivatives and their use in the treatment of thrombocythemia
    Publication number: 20060052601
    Abstract: A method for the treatment of thrombocythemia in a subject comprising administering a therapeutically effective amount of compounds having the formulas (I) through (III) or equilibrating forms thereof.
    Type: Application
    Filed: August 3, 2005
    Publication date: March 9, 2006
    Applicant: Shire Holdings AG
    Inventor: Richard Franklin
  • Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
    Publication number: 20060030574
    Abstract: In accordance with the present invention there is provided a method for the treatment of peripheral arterial diseases in a host comprising administering a therapeutically effective amount of compounds having the formulas (I) through (III) or analogues thereof.
    Type: Application
    Filed: August 3, 2005
    Publication date: February 9, 2006
    Applicant: Shire Holdings AG
    Inventor: Richard Franklin
  • Treatment of bone diseases
    Publication number: 20020051822
    Abstract: The invention provides a method for enhancing bone formation, inhibiting osteoclastic differentiation and/or activating osteoblastic differentiation whereby to manage, treat or achieve prophylaxis of bone disease which comprises administering to a human or animal subject suffering from, or susceptible to bone disease a therapeutically or prophylactically effective amount of a lanthanum compound.
    Type: Application
    Filed: June 26, 2001
    Publication date: May 2, 2002
    Applicant: Shire Holdings AG
    Inventors: Nigel D. Atherton, Joseph W. Totten, Michael D. Gaitonde